Expression and function of peroxisome proliferator-activated receptors in human melanocytes
Authors:
- 19 March 2004
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 150 (3) , 462-468
Abstract
Background Peroxisome proliferator-activated receptors (PPARs) belong to the superfamily of nuclear receptors that heterodimerize with the retinoic X receptor. Agonists of PPAR have been known to play an important role in cellular responses including proliferation and differentiation. The expression and function of PPARs have not been investigated in human melanocytes, although they have been widely demonstrated in keratinocytes of the skin. Objectives To investigate the expression of PPARs in human melanocytes and the effects of PPAR activators on melanocyte growth and melanogenesis. Methods We used immunocytochemistry and Western blot analysis to determine whether PPARs are expressed in melanocytes. To investigate further expression of PPAR subtypes, reverse transcriptase–polymerase chain reaction analysis was performed using PPAR subtype-specific oligonucleotides. The cell proliferation was measured using the Coulter counter. The effects on pigmentation were investigated with measurement of melanin contents, tyrosinase activity and its expression. Results The mRNA of all three PPAR subtypes, PPAR-α, PPAR-β/δ and PPAR-γ, were expressed in melanocytes. Activators for PPAR-α (WY-14643) and PPAR-γ (ciglitazone) inhibited proliferation of melanocytes in a dose-dependent manner, whereas bezafibrate, a preferential activator for PPAR-β/δ, had no effect. This growth inhibition was accompanied by the morphological change of the melanocytes to an activated form with an increased number of dendrites and enlarged cell area compared with the control. The WY-14643 and ciglitazone also appeared to stimulate the melanin synthesis of melanocytes. This increase in pigmentation was due to stimulation of the tyrosinase activity without an increase in the expression of tyrosinase. Conclusions PPARs are expressed in human melanocytes and PPAR-α and PPAR-γ activators inhibit melanocyte growth and stimulate melanogenesis.Keywords
This publication has 28 references indexed in Scilit:
- Agonists of Peroxisome Proliferator-Activated Receptor γ Inhibit Cell Growth in Malignant MelanomaJournal of Investigative Dermatology, 2002
- Differentiation of Murine Melanocyte Precursors Induced by 1,25-Dihydroxyvitamin D3 Is Associated with the Stimulation of Endothelin B Receptor ExpressionJournal of Investigative Dermatology, 2002
- All-trans Retinoic Acid Induces Differentiation and Apoptosis of Murine Melanocyte Precursors with Induction of the Microphthalmia-Associated Transcription FactorJournal of Investigative Dermatology, 2002
- Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo.British Journal of Dermatology, 2001
- Impaired skin wound healing in peroxisome proliferator–activated receptor (PPAR)α and PPARβ mutant miceJournal of Cell Biology, 2001
- Differential Expression of Peroxisome Proliferator-Activated Receptor Subtypes During the Differentiation of Human KeratinocytesJournal of Investigative Dermatology, 1998
- Peroxisome proliterator-activated receptors, orphans with ligands and functionsCurrent Opinion in Lipidology, 1997
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990
- Retinoic Acid is a Potent Inhibitor of Inducible Pigmentation in Murine and Hamster Melanoma Cell LinesJournal of Investigative Dermatology, 1990
- Enhancement of melanotic expression in cultured mouse smelanoma cells by retinoidsJournal of Cellular Physiology, 1981